Nippon Shinyaku Co., Ltd. (TYO:4516)

Market Cap	218.91B
Revenue (ttm)	160.65B
Net Income (ttm)	30.55B
Shares Out	67.38M
EPS (ttm)	453.40
PE Ratio	7.17
Forward PE	9.41
Dividend	124.00 (3.82%)
Ex-Dividend Date	Sep 29, 2025

Volume	127,500
Average Volume	295,255
Open	3,258.00
Previous Close	3,258.00
Day's Range	3,241.00 - 3,263.00
52-Week Range	2,967.00 - 4,414.00
Beta	-0.32
RSI	46.31
Earnings Date	Nov 14, 2025

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1911
• Employees: 2,243
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4516

Financial Performance

In 2024, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.